Introduction
The Bacillus Thuringiensis Aizawai market is highly consolidated at the level of strain ownership and manufacturing. Only two Bt aizawai strains, ABTS-1857 and GC-91, hold active-substance approval in the European Union, and both are controlled by Japanese-owned groups: ABTS-1857 by Sumitomo Chemical through its biorational business (Valent BioSciences, which became part of Sumitomo Biorational Company in 2026), and GC-91 by the Mitsui & Co. group through Certis Biologicals in the United States and Certis Belchim / Mitsui AgriScience International in Europe. These two groups supply the leading global brands, XenTari on one side and Agree and Turex on the other, and account for the majority of the market's value.
Around the two strain owners operates a second layer of national registrants and distributors that hold local registrations, manage market access and provide agronomic support. Examples include Nufarm, which distributes an ornamental-use XenTari WG product in Canada; Bio Controle, which registers and markets Agree in Brazil; Endeavour, which holds the Brazilian registration for the liquid Bt aizawai product Biossela; and Vita Bee Health, which markets an ABTS-1857-based product for wax moth control in beekeeping, developed with Valent BioSciences. In Asia, domestic Bt manufacturers in China and India add price competition, although most of their output is based on other subspecies.
Competition between aizawai brands is moderate. The more significant rivalry is with alternative modes of action for caterpillar control, including Bt kurstaki, baculoviruses, spinosyns and synthetic insecticides such as diamides and avermectins. Competitive advantage rests on strain performance and efficacy data, registrations across crops and countries, fermentation scale and cost, formulation quality, and the ability to offer technical support and integrated pest management programmes. Recent strategic activity has centred on corporate consolidation of biological businesses, investment in fermentation and research capacity, and acquisitions that broaden biological portfolios and distribution.
Key Player Positioning
Leaders
Sumitomo Chemical Co., Ltd. (Sumitomo Biorational Company LLC, formerly Valent BioSciences LLC): Owner of the ABTS-1857 strain and the XenTari brand, registered in markets across North America, Europe, Latin America, Africa and Asia. Its biorational business combines fermentation capacity in Osage, Iowa, with research facilities in Libertyville, Illinois, and was reorganised as Sumitomo Biorational Company, which began operations in April 2026. The parent group reported sales revenue of JPY 2,328.5 billion for the fiscal year ended March 2026.
Mitsui & Co., Ltd. (Certis Biologicals): Owner of the GC-91 strain through its Certis businesses. Certis Biologicals, based in Columbia, Maryland, markets Agree WG in the United States and manufactures product supplied to partners in other markets, including Brazil. Its portfolio includes more than 40 biological products. The parent group reported revenue of approximately JPY 14.0 trillion for the fiscal year ended March 2026.
Challengers
Certis Belchim B.V. / Mitsui AgriScience International (Mitsui & Co. group): Formed in 2022 through the merger of Certis Europe and Belchim Crop Protection, it markets GC-91-based products such as Agree and Turex in Europe and combines biological and conventional crop protection products in a single regional portfolio.
Nufarm Limited: An Australian-headquartered crop protection company that distributes an ornamental-use XenTari WG product in Canada, providing access to professional horticulture and ornamental channels.
Niche Players
Vita Bee Health (Vita (Europe) Ltd): Specialist in honey bee health products; markets B402 (Certan), a liquid ABTS-1857 formulation for greater wax moth control in stored comb, approved by the U.S. EPA and available in the United States and parts of Canada.
Bio Controle – Métodos de Controle de Pragas Ltda.: Brazilian registrant and marketer of Agree WP (GC-91), manufactured by Certis.
Endeavour: Brazilian registrant of Biossela, a liquid Bt aizawai formulation registered with the Ministry of Agriculture and Livestock.
Threat of New Entrants: Low
Approval of a new microbial active substance requires extensive strain characterisation and safety data, and registration must then be secured country by country.
Only two Bt aizawai strains are approved in the EU, both owned by established Japanese-owned groups with long registration histories.
Large-scale fermentation capacity and formulation know-how require significant capital and technical expertise.
Bargaining Power of Suppliers: Low
Fermentation media are based on widely available agricultural commodities with many alternative suppliers.
The critical input, the proprietary strain, is owned by the manufacturers themselves.
Formulation co-formulants and packaging are sourced from competitive chemical and packaging markets.
Bargaining Power of Buyers: Medium
Large distributors and grower groups negotiate on price and can switch to other bioinsecticides or to synthetic insecticides.
Buyer power is reduced where aizawai is needed for resistance management or for residue and organic compliance.
Fragmented smallholder demand in emerging markets limits the bargaining power of individual end users.
Threat of Substitutes: High
Bt kurstaki products, baculoviruses (such as Spodoptera and Helicoverpa nucleopolyhedroviruses), spinosyns and botanical insecticides compete for the same lepidopteran pest uses.
Synthetic insecticides, including diamides and avermectins, offer faster and longer-lasting control at competitive prices.
Genetically modified Bt crops reduce the need for foliar sprays against some caterpillar pests in maize, cotton and soybean.
Competitive Rivalry: Medium
Direct rivalry between aizawai brands is limited because the market is concentrated around two strain owners.
Rivalry is stronger with other biological and synthetic insecticides, and suppliers compete on efficacy data, technical support and integrated programmes.
Investment in capacity, new formulations and emerging-market registrations is increasing competitive intensity.
Threat of New Entrants: Low; High regulatory, intellectual property and fermentation barriers.
Bargaining Power of Suppliers: Low; Commodity-based inputs; strains owned by manufacturers.
Bargaining Power of Buyers: Medium; Distributors can switch products; power limited by resistance and residue needs.
Threat of Substitutes: High; Other bioinsecticides, synthetic insecticides and Bt crops.
Competitive Rivalry: Medium; Concentrated supply; rivalry mainly with alternative modes of action.
